The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Cosmed sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Cosmed Srl (Cosmed) is a medical device company that develops cardiopulmonary and metabolic diagnostic equipment. The company’s products include cardio pulmonary exercise test, indirect calorimetry, pulmonary function test, spirometry equipments, body composition, stress testing ECG, ergometers, accessories.accessory *products include blood pressure accessories, cardiac output, cart accessories, calibration syringe, aquatrainer, bluetooth pulse, oximeter, ethanol burning kit, pulse oximeter, face masks, respiratory filters. It markets its products under the brands microQuark, Quark SPIRO, Quark PFT, Q-BOX, Vivatmo, R-Tube, BOD POD GS-X, PEA POD, COSMED Line, and MONARK Line. Cosmed is headquartered in Rome, Italy.
The key metrics of Cosmed related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Cosmed is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Cosmed.
For a detailed understanding of the performance of Cosmed, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
